SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Canadian Cancer Society's Steering Committee. Canadian Cancer Statistics 2011. Toronto, Canada: Canadian Cancer Society; 2011.
  • 2
    Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A, editors. AJCC Cancer Staging Manual. 7th edition. New York, NY: Springer; 2010.
  • 3
    Enker WE, Laffer UT, Block GE. Enhanced survival of patients with colon and rectal cancer is based upon wide anatomic resection. Ann Surg. 1979; 190: 350-360.
  • 4
    McDermott FT, Hughes ES, Pihl E, Milne BJ, Price AB. Comparative results of surgical management of single carcinomas of the colon and rectum: a series of 1939 patients managed by one surgeon. Br J Surg. 1981; 68: 850-855.
  • 5
    Phillips RK, Hittinger R, Blesovsky L, Fry JS, Fielding LP. Large bowel cancer: surgical pathology and its relationship to survival. Br J Surg. 1984; 71: 604-610.
  • 6
    NIH consensus conference. Adjuvant therapy for patients with colon and rectal cancer. JAMA. 1990; 264: 1444-1450.
  • 7
    Figueredo A, Fine S, Maroun J, Walker-Dilks C, Wong S. Adjuvant therapy for stage III colon cancer after complete resection. Provincial Gastrointestinal Disease Site Group. Cancer Prev Control. 1997; 1: 314-319.
  • 8
    Sauer R, Becker H, Hohenberger W, et al; German Rectal Cancer Study Group. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med. 2004; 351: 1731-1740.
  • 9
    Wu XC, Yu Q, Andrews PA, et al. Comparisons of directly coded SEER Summary Stage 2000 and Collaborative Staging Derived SEER Summary Stage 2000. J Registry Manag. 2010; 37: 137-140.
  • 10
    American Joint Committee on Cancer. Collaborative stage data collection system: about us. http://www.cancerstaging.org/cstage/about.html. Accessed February, 28 2012.
  • 11
    Urquhart R, Porter G, Bu J, Dewar R, Grunfeld E. Poor Stage IIB survival in a population-based cohort of colorectal cancer patients [Abstract]. Can J Gastroenterol. 2010; 24( suppl A): 68A.
  • 12
    Gunderson LL, Jessup JM, Sargent DJ, Greene FL, Stewart AK. Revised TN categorization for colon cancer based on national survival outcomes data. J Clin Oncol. 2010; 28: 264-271.
  • 13
    O'Connell JB, Maggard MA, Ko CY. Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging. J Natl Cancer Inst. 2004; 96: 1420-1425.
  • 14
    Gunderson LL, Jessup JM, Sargent DJ, Greene FL, Stewart A. Revised tumor and node categorization for rectal cancer based on surveillance, epidemiology, and end results and rectal pooled analysis outcomes. J Clin Oncol. 2010; 28: 256-263.
  • 15
    Gunderson L, Sargent D, Tepper J, et al. Impact of T and N stage and treatment on survival and relapse in adjuvant rectal cancer: a pooled analysis. J Clin Oncol. 2004; 22: 1785-1796.
  • 16
    Kozak K, Moody J. The impact of T and N stage on long-term survival of rectal cancer patients in the community. J Surg Oncol. 2008; 98: 161-166.
  • 17
    Shepherd N, Baxter K, Love S. The prognostic importance of peritoneal involvement in colonic cancer: a prospective evaluation. Gastroenterology. 1997; 112: 1096-1102.
  • 18
    Collaborative Stage Work Group of the American Joint Committee on Cancer. Collaborative Stage Data Collection System Coding Instructions, Version 01.04.00. Incorporates updates through October 31, 2007. Chicago, IL: American Joint Committee on Cancer; 2007.
  • 19
    Fritz A, Percy C, Jack A, editors. International Classification of Diseases for Oncology (ICD-O). Third edition. Geneva, Switzerland: World Health Organization; 2000.
  • 20
    Urquhart R, Rayson D, Porter GA, Grunfeld E. Quantifying limitations in chemotherapy data in administrative health databases: implications for measuring the quality of colorectal cancer care. Healthc Policy. 2011; 7: 32-40.
  • 21
    Elixhauser A, Steiner C, Harris D, Coffey R. Comorbidity measures for use with administrative data. Med Care. 1998; 36: 8-27.
  • 22
    Greene FL, Page DL, Fleming ID, et al, editors. AJCC Cancer Staging Manual. 6th edition. New York, NY: Springer-Verlag; 2002.
  • 23
    Phillips JL, Gress DM. Comparison of registrar collaborative staging and physician AJCC staging using data submitted to the National Cancer Data Base. J Registry Manag. 2008; 35: 4-11.
  • 24
    Chang GJ, Rodriguez-Bigas MA, Skibber JM, Moyer VA. Lymph node evaluation and survival after curative resection of colon cancer: systematic review. J Natl Cancer Inst. 2007; 99: 433-441.
  • 25
    Chen SL, Bilchik AJ. More extensive nodal dissection improves survival for stages I to III of colon cancer: a population-based study. Ann Surg. 2006; 244: 602-610.
  • 26
    Johnson PM, Malatjalian D, Porter GA. Adequacy of nodal harvest in colorectal cancer: a consecutive cohort study. J Gastrointest Surg. 2002; 6: 883-888.
  • 27
    Johnson PM, Porter GA, Ricciardi R, Baxter NN. Increasing negative lymph node count is independently associated with improved long-term survival in stage IIIB and IIIC colon cancer. J Clin Oncol. 2006; 24: 3570-3575.
  • 28
    Le Voyer TE, Sigurdson ER, Hanlon AL, et al. Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089. J Clin Oncol. 2003; 21: 2912-2919.
  • 29
    Carloss H, Huang B, Cohen A, Carloss E, Wyatt S, Tucker T. The impact of number of lymph nodes removed on five-year survival in stage II colon and rectal cancer. J Ky Med Assoc. 2004; 102: 345-347.
  • 30
    Jestin P, Påhlman L, Glimelius B, Gunnarsson U. Cancer staging and survival in colon cancer is dependent on the quality of the pathologists' specimen examination. Eur J Cancer. 2005; 41: 2071-2078.
  • 31
    Swanson RS, Compton CC, Stewart AK, Bland KI. The prognosis of T3N0 colon cancer is dependent on the number of lymph nodes examined. Ann Surg Oncol. 2003; 10: 65-71.
  • 32
    Bickell NA, Chassin MR. Determining the quality of breast cancer care: do tumor registries measure up? Ann Intern Med. 2000; 132: 705-710.
  • 33
    Canadian Partnership Against Cancer. The System Performance Initiative: A First Year Report. Toronto, Canada: Candian Partnership Against Cancer; 2009.
  • 34
    Malin JL, Kahn KL, Adams J, Kwan L, Laouri M, Ganz PA. Validity of cancer registry data for measuring the quality of breast cancer care. J Natl Cancer Inst. 2002; 94: 835-844.
  • 35
    Duong LM, Ajani UA, Wilson RJ. Comparative evaluation of uterine cancer staging data using two different staging systems, 2001-2005. J Registry Manag. 2009; 36: 125-129.